Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update

Go back to Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update
(NASDAQ: TSHA) Delayed: 5.22 +0.15 (2.96%)
Previous Close $5.07    52 Week High
Open $5.25    52 Week Low
Day High $5.46    P/E N/A 
Day Low $5.18    EPS
Volume 1,245,368